HGBL With MYC and BCL2 and/or BCL6 Rearrangements

Explore clinical trials studying HGBL With MYC and BCL2 and/or BCL6 Rearrangements. Study availability and eligibility vary by location and protocol.

2 public trials 2 recruiting studies

Refine in advanced search Browse all conditions

HGBL With MYC and BCL2 and/or BCL6 Rearrangements trial results

Recruiting

NCT06544265

Conditions: Aggressive B-Cell Non-Hodgkin Lymphoma, B Cell Lymphoma, Blood Protein Disorders, +54 more
Locations: Colorado Blood Cancer Institute, part of Sarah Cannon Cancer Institute Denver, Colorado, United States

Winship Cancer Institute of Emory University Atlanta, Georgia, United States

The University of Kansas Cancer Center Fairway, Kansas, United States

Rutgers Cancer Institute New Brunswick, New Jersey, United States

Recruiting

NCT06830031

Conditions: DLBCL, Nos Genetic Subtypes, Dendritic Cell Sarcoma, Interdigitating, Diffuse Large B-cell-lymphoma, +22 more
Locations: Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences Tianjin, China